Maynard Um
-
-
-
-
-
-
-
Praxis Precision Medicines Inc. (PRAX) PT Lowered to $616 at Truist Securities
-
-
-
-
-
-
-
Praxis Precision Medicines Inc. (PRAX) PT Raised to $550 at Jefferies
-
-
-
-
-
-
-
Bernstein on US Pharma and Biotech: Who might buy whom?
-
-
-
-
-
-
-
Praxis Precision Medicines (PRAX) Misses Q4 EPS by 41c
-
-
-
-
-
-
-
Praxis plans two drug applications by mid-February, raises $1.5 billion
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX)
-
-
-
-
-
-
-
Praxis plans to file NDA for relutrigine in rare epilepsies by early 2026
-
422,988 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

